trial · primary record
JNJ-90301900 (NBTXR3)
Carcinoma, Squamous Cell
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2028-06-30 |
| Primary endpoint | Progression-free Survival (PFS) Based on Independent Central Review (ICR) |
| Registry ID | NCT04892173 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:30.649Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04892173
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-90301900 · compound